APA (7th ed.) Citation

FA, G., GI, R., DW, S., R, H., S, L., DA, Y., . . . JD, H. (2004). Carcinoma of unknown primary site: Sequential treatment with paclitaxel/carboplatin/etoposide and gemcitabine/irinotecan: a Minnie Pearl Cancer Research Network phase II trial. The oncologist, 9(6), 644. https://doi.org/10.1634/theoncologist.9-6-644

Chicago Style (17th ed.) Citation

FA, Greco, et al. "Carcinoma of Unknown Primary Site: Sequential Treatment with Paclitaxel/carboplatin/etoposide and Gemcitabine/irinotecan: A Minnie Pearl Cancer Research Network Phase II Trial." The Oncologist 9, no. 6 (2004): 644. https://doi.org/10.1634/theoncologist.9-6-644.

MLA (9th ed.) Citation

FA, Greco, et al. "Carcinoma of Unknown Primary Site: Sequential Treatment with Paclitaxel/carboplatin/etoposide and Gemcitabine/irinotecan: A Minnie Pearl Cancer Research Network Phase II Trial." The Oncologist, vol. 9, no. 6, 2004, p. 644, https://doi.org/10.1634/theoncologist.9-6-644.